VJHemOnc is committed to improving our service to you

EBMT 2019 | CAR T-cell therapy: what clinicians need to know about managing the AEs

VJHemOnc is committed to improving our service to you

David Maloney

From the European Society for Blood and Marrow Transplantation (EBMT) 2019 Annual Meeting, held in Frankfurt, Germany, David Maloney, MD, PhD, of Fred Hutchinson Cancer Research Center, Seattle, WA, talks about the adverse events associated with CAR T-cell therapy and what clinicians need to be aware of.

Share this video  
Similar topics

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter